{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:14:24Z","timestamp":1792012464137,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["neurotox res"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/bf03033576","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:41:58Z","timestamp":1248111718000},"page":"71-78","source":"Crossref","is-referenced-by-count":84,"title":["Developing translational animal models for symptoms of schizophrenia or bipolar mania"],"prefix":"10.1007","volume":"14","author":[{"given":"Mark A.","family":"Geyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03033576_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archpsyc.1990.01810140081011","volume":"47","author":"DL Braff","year":"1990","unstructured":"Braff DL and MA Geyer (1990) Sensorimotor gating and schizophrenia: human and animal model studies.Arch. Gen. Psychiatry 47, 181\u2013188.","journal-title":"Arch. Gen. Psychiatry"},{"key":"BF03033576_CR2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","volume":"156","author":"DL Braff","year":"2001","unstructured":"Braff DL, MA Geyer and NR Swerdlow (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.Psychopharmacology 156, 234\u2013258.","journal-title":"Psychopharmacology"},{"key":"BF03033576_CR3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0022-3565(25)12637-2","volume":"254","author":"CW Callaway","year":"1990","unstructured":"Callaway CW, LL Wing and MA Geyer (1990) Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.J. Pharmacol. Exp. Ther. 254, 456\u2013464.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03033576_CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00213-004-2139-5","volume":"180","author":"J Cilia","year":"2005","unstructured":"Cilia J, PD Hatcher, C Reavill and DNC Jones (2005) Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats: an update.Psychopharmacology 180, 57\u201362.","journal-title":"Psychopharmacology"},{"key":"BF03033576_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YCO.0b013e3280117733","volume":"20","author":"JF Cryan","year":"2007","unstructured":"Cryan JF and DA Slattery (2007) Animal models of mood disorders: recent developments.Curr. Opin. Psychiatry 20, 1\u20137.","journal-title":"Curr. Opin. Psychiatry"},{"key":"BF03033576_CR6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.npp.1301421","volume":"33","author":"PA Csomor","year":"2008","unstructured":"Csomor PA, RR Stadler, J Feldon, BK Yee, MA Geyer and FX Vollenweider (2008) Haloperidol differentially modulates prepulse inhibition and P50 suppression in healthy humans stratified for low and high gating levels.Neuropsychopharmacology 33, 497\u2013512.","journal-title":"Neuropsychopharmacology"},{"key":"BF03033576_CR7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0149-7634(01)00022-7","volume":"25","author":"D Drai","year":"2001","unstructured":"Drai D and I Golani (2001) SEE: a tool for the visualization and analysis of rodent exploratory behavior.Neurosci. Biobehav. Rev. 25, 409\u2013426.","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BF03033576_CR8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.neubiorev.2005.08.003","volume":"30","author":"D Eilam","year":"2006","unstructured":"Eilam D, R Zor, H Szechtman and H Hermesh (2006) Rituals, stereotypy and compulsive behavior in animals and humans.Neurosci. Biobehav. Rev. 30, 456\u2013471.","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BF03033576_CR9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0269881106060241","volume":"20","author":"H Einat","year":"2006","unstructured":"Einat H (2006) Modelling facets of mania \u2014 new directions related to the notion of endophenotypes.J. Psychopharmacology (Oxford, England)20, 714\u2013722.","journal-title":"J. Psychopharmacology"},{"key":"BF03033576_CR10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbr.2007.04.020","volume":"181","author":"D Feifel","year":"2007","unstructured":"Feifel D, G Melendez, K Priebe, PD Shilling (2007) The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats.Behav. Brain Res. 181, 278\u201386.","journal-title":"Behav. Brain Res."},{"key":"BF03033576_CR11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-003-1564-1","volume":"169","author":"WS Fenton","year":"2003","unstructured":"Fenton WS, EL Stover and TR Insel (2003) Breaking the logjam in treatment development for cognition in schizophrenia.Psychopharmacology 169, 365\u2013366.","journal-title":"Psychopharmacology"},{"key":"BF03033576_CR12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/schbul\/sbi041","volume":"31","author":"S Floresco","year":"2005","unstructured":"Floresco S, MA Geyer, LH Gold and A Grace (2005) Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia.Schizophr. Bull. 31, 888\u2013894.","journal-title":"Schizophr. Bull."},{"key":"BF03033576_CR13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0006-3223(98)00321-7","volume":"45","author":"R Freedman","year":"1999","unstructured":"Freedman R, LE Adler and S Leonard (1999) Alternative phenotypes for the complex genetics of schizophrenia.Biol. Psychiatry 45, 551\u2013558.","journal-title":"Biol. Psychiatry"},{"key":"BF03033576_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.31887\/DCNS.2006.8.1\/mgeyer","volume":"8","author":"MA Geyer","year":"2006","unstructured":"Geyer MA (2006) Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?Dialogues Clin. Neurosci. 8, 9\u201316.","journal-title":"Dialogues Clin. Neurosci."},{"key":"BF03033576_CR15","first-page":"1071","volume":"27","author":"MA Geyer","year":"2003","unstructured":"Geyer MA and BA Ellenbroek (2003) Animal behavior models of the mechanisms underlying antipsychotic atypicality. Prog. Neuropsychopharmacol.Biol. Psychiatry 27, 1071\u20131079.","journal-title":"Biol. Psychiatry"},{"key":"BF03033576_CR16","volume-title":"Measuring Movement and Locomotion: From Invertebrates to Humans","author":"MA Geyer","year":"1996","unstructured":"Geyer MA and M Paulus (1996) Multivariate analyses of locomotor and investigatory behavior in rodents, In:Measuring Movement and Locomotion: From Invertebrates to Humans (Ossenkopp K, M Kavaliers & PR Sanberg, Eds.) (Chapman & Hall:New York, NY)."},{"key":"BF03033576_CR17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0091-3057(86)90266-2","volume":"25","author":"MA Geyer","year":"1986","unstructured":"Geyer MA, PV Russo and VL Masten (1986) Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses.Pharmacol. Biochem. Behav. 25, 277\u2013288.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BF03033576_CR18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","volume":"156","author":"MA Geyer","year":"2001","unstructured":"Geyer MA, K Krebs-Thomson, DL Braff and NR Swerdlow (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.Psychopharmacology 156, 117\u2013154.","journal-title":"Psychopharmacology"},{"key":"BF03033576_CR19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/sj.mp.4001159","volume":"7","author":"MA Geyer","year":"2002","unstructured":"Geyer MA, KL McIlwain and R Paylor (2002) Mouse genetic models for prepulse inhibition: an early review.Mol. Psychiatry 7, 1039\u20131053.","journal-title":"Mol. Psychiatry"},{"key":"BF03033576_CR20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/ajp.153.3.321","volume":"153","author":"MF Green","year":"1996","unstructured":"Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia?Am. J. Psychiatry 153, 321\u2013330.","journal-title":"Am. J. Psychiatry"},{"key":"BF03033576_CR21","first-page":"45","volume":"72","author":"MF Green","year":"2004","unstructured":"Green MF, SR Kerns and RK Heaton (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.Schizophr. Res. 72, 45\u201351.","journal-title":"Schizophr. Res."},{"key":"BF03033576_CR22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/schbul\/sbi058","volume":"31","author":"JJ Hagan","year":"2005","unstructured":"Hagan JJ and DN Jones (2005) Predicting drug efficacy for cognitive deficits in schizophrenia.Schizophr. Bull. 31, 830\u2013853.","journal-title":"Schizophr. Bull."},{"key":"BF03033576_CR23","doi-asserted-by":"crossref","first-page":"139S","DOI":"10.1016\/j.biopsych.2006.11.008","volume":"61","author":"MJ Kincaid","year":"2007","unstructured":"Kincaid MJ, A Minassian, EJ Ferguson, MA Geyer, MP Paulus and W Perry (2007) Exploratory behavior differentiates patients with acute psychotic mania from schizophrenia.Biol. Psychiatry 61, 139S.","journal-title":"Biol. Psychiatry"},{"key":"BF03033576_CR24","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1176\/ajp.156.7.1046","volume":"156","author":"V Kumari","year":"1999","unstructured":"Kumari V, W Soni and T Sharma (1999) Normalization of information processing deficits in schizophrenia with clozapine.Am. J. Psychiatry 156, 1046\u20131051.","journal-title":"Am. J. Psychiatry"},{"key":"BF03033576_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-3223(02)01925-X","volume":"54","author":"K Ludewig","year":"2003","unstructured":"Ludewig K, MA Geyer and FX Vollenweider (2003) Deficits in prepulse inhibition and habituation in never-medicated firstepisode schizophrenia.Biol. Psychiatry 54, 121\u2013128.","journal-title":"Biol. Psychiatry"},{"key":"BF03033576_CR26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.schres.2004.09.010","volume":"72","author":"SR Marder","year":"2004","unstructured":"Marder SR and W Fenton (2004) Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia.Schizophr. Res. 72, 5\u20139.","journal-title":"Schizophr. Res."},{"key":"BF03033576_CR27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00213-003-1750-1","volume":"174","author":"LF Martin","year":"2004","unstructured":"Martin LF, WR Kem and R Freedman (2004) Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.Psychopharmacology 174, 54\u201364.","journal-title":"Psychopharmacology"},{"key":"BF03033576_CR28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","volume":"25","author":"HY Meltzer","year":"1999","unstructured":"Meltzer HY and SR McGurk (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.Schizophr. Bull. 25, 233\u2013255.","journal-title":"Schizophr. Bull."},{"key":"BF03033576_CR29","first-page":"222S","volume":"61","author":"A Minassian","year":"2007","unstructured":"Minassian A, MA Geyer, MP Paulus, EJ Ferguson, R Sharp and W Perry (2007) Quantification of motor hyperactivity in mania: the human behavioral pattern monitorBiol. Psychiatry 61, 222S.","journal-title":"Biol. Psychiatry"},{"key":"BF03033576_CR30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2004.09.007","volume":"72","author":"KH Nuechterlein","year":"2004","unstructured":"Nuechterlein KH, DM Barch, JM Gold, TE Goldberg, MF Green and RK Heaton (2004) Identification of separable cognitive factors in schizophrenia.Schizophr. Res. 72, 29\u201339.","journal-title":"Schizophr. Res."},{"key":"BF03033576_CR31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s002130100828","volume":"156","author":"B Olivier","year":"2001","unstructured":"Olivier B, C Leahy, T Mullen, R Paylor, FE Groppi, Z Sarnyai and D Brunner (2001) The DBA\/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?Psychopharmacology 156, 284\u2013290.","journal-title":"Psychopharmacology"},{"key":"BF03033576_CR32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002130100763","volume":"156","author":"A-M Ouagazzal","year":"2001","unstructured":"Ouagazzal A-M, F Jenck and J-L Moreau (2001) Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity.Psychopharmacology 156, 273\u2013283.","journal-title":"Psychopharmacology"},{"key":"BF03033576_CR33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1037\/0735-7044.114.2.374","volume":"114","author":"AA Palmer","year":"2000","unstructured":"Palmer AA, SC Dulawa, AA Mottiwala, LH Conti, MA Geyer and MP Printz (2000) Prepulse startle deficit in the Brown-Norway rat. A potential genetic model.Behav. Neurosci. 114, 374\u2013388.","journal-title":"Behav. Neurosci."},{"key":"BF03033576_CR34","first-page":"227S","volume":"61","author":"MP Paulus","year":"2007","unstructured":"Paulus MP, A Minassian, V Masten, D Feifel, MA Geyer and W Perry (2007) Human behavioral pattern monitor differentiates activity patterns of bipolar manic and attention deficit hyperactivity subjects.Biol. Psychiatry 61, 227S.","journal-title":"Biol. Psychiatry"},{"key":"BF03033576_CR35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0006-3223(01)01184-2","volume":"50","author":"W Perry","year":"2001","unstructured":"Perry W, A Minassian, D Feifel and DL Braff (2001) Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania.Biol. Psychiatry 50, 418\u2013424.","journal-title":"Biol. Psychiatry"},{"key":"BF03033576_CR36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/10298420290030578","volume":"4","author":"SB Powell","year":"2002","unstructured":"Powell SB and MA Geyer (2002) Developmental markers of psychiatric disorders as identified by sensorimotor gating.Neurotox. Res. 4, 489\u2013502.","journal-title":"Neurotox. Res."},{"key":"BF03033576_CR37","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/sj.npp.1301161","volume":"31","author":"VB Risbrough","year":"2006","unstructured":"Risbrough VB, VL Masten, S Caldwell, MP Paulus, MJ Low and MA Geyer (2006) Differential contributions of dopamine D(1), D(2), and D(3) receptors to MDMA-induced effects on locomotor behavior patterns in mice.Neuropsychopharmacology 31, 2349\u20132358.","journal-title":"Neuropsychopharmacology"},{"key":"BF03033576_CR38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0091-3057(93)90193-W","volume":"44","author":"NR Swerdlow","year":"1993","unstructured":"Swerdlow NR and MA Geyer (1993) Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.Pharmacol. Biochem. Behav. 44, 741\u2013744.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BF03033576_CR39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002130100799","volume":"156","author":"NR Swerdlow","year":"2001","unstructured":"Swerdlow NR, MA Geyer and DL Braff (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges.Psychopharmacology 156, 194\u2013215.","journal-title":"Psychopharmacology"},{"key":"BF03033576_CR40","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/sj.npp.1301043","volume":"31","author":"NR Swerdlow","year":"2006","unstructured":"Swerdlow NR, J Talledo, AN Sutherland, D Nagy and JM Shoemaker (2006) Antipsychotic effects on prepulse inhibition in normal \u2018low gating\u2019 humans and rats.Neuropsychopharmacology 31, 2011\u20132021.","journal-title":"Neuropsychopharmacology"},{"key":"BF03033576_CR41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.biopsych.2006.03.058","volume":"60","author":"FX Vollenweider","year":"2006","unstructured":"Vollenweider FX, M Barro, PA Csomor and J Feldon (2006) Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels.Biol. Psychiatry 60, 597\u2013603.","journal-title":"Biol. Psychiatry"},{"key":"BF03033576_CR42","unstructured":"Young, J, MA Geyer, and the TURNS Preclinical Subcommittee (2006) Cognitive task list and preclinical task survey. http:\/\/www.turns.ucla.edu\/preclinical-TURNS-report-2006b.pdf"},{"key":"BF03033576_CR43","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.neubiorev.2007.05.009","volume":"31","author":"JW Young","year":"2007","unstructured":"Young JW, A Minassian, MP Paulus, MA Geyer and W Perry (2007a) A reverse-translational approach to bipolar disorder: rodent and human studies in the behavioral pattern monitor.Neurosci. Biobehav. Rev. 31, 882\u2013896.","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BF03033576_CR44","doi-asserted-by":"crossref","first-page":"38S","DOI":"10.1016\/j.biopsych.2006.08.047","volume":"61","author":"JW Young","year":"2007","unstructured":"Young JW, AKL Goey, VL Masten, R Sharp, MP Paulus, W Perry and MA Geyer (2007b) Genetic and acute pharmacological animal models of bipolar disorder mania: mimicking recent insights of disordered movement and exploration.Biol. Psychiatry 61, 38S.","journal-title":"Biol. Psychiatry"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033576.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03033576\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T05:30:37Z","timestamp":1739251837000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03033576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["BF03033576"],"URL":"https:\/\/doi.org\/10.1007\/bf03033576","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}